Correspondence on 'Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry'

Ann Rheum Dis. 2023 Jun;82(6):e138. doi: 10.1136/annrheumdis-2021-220588. Epub 2021 May 13.
No abstract available

Keywords: Covid-19; ankylosing; anti-inflammatory agents; biological therapy; non-steroidal; spondylitis; sulfasalazine.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antirheumatic Agents* / therapeutic use
  • COVID-19* / complications
  • Humans
  • Registries
  • Rheumatic Diseases* / drug therapy
  • Rheumatology*

Substances

  • Antirheumatic Agents